Patient-based screening register of a consecutive patient cohort for cystic pancreatic masses (Magdeburg cyst passport concept)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033939

Enrollment

1000

Registered

2024-03-25

Start date

2023-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K86.2 K86.3 K86.8 K86.9

Interventions

Group 1: The patients with cystic pancreatic tumor lesions identified through new diagnosis (initial diagnosis), follow-up checks and surgical therapy as well as their follow-up care should be provide

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with cystic pancreatic tumor lesions detected twice by imaging (complementary diagnostic procedures) and/or histologically proven

Exclusion criteria

Exclusion criteria: - without evidence of a pancreatic tumor lesion - with pseudocyst - with manifest pancreatic cancer - < 18 years

Design outcomes

Primary

Measure	Time frame
Surgical-early postoperative & long-term oncosurgical outcome of the cystic pancreatic tumor lesions requiring surgery	—

Secondary

Measure	Time frame
Agreement rate between suspected imaging diagnosis and definitive histopathological diagnosis	—

Countries

Germany

Contacts

Public ContactFrank Meyer

Universitätsklinik für Allgemein-, Viszeral-, Gefäß- und Transplantationschirurgie

f.meyer@med.ovgu.de+49-391-67-15682

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026